Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Receives $19.80 Consensus PT from Analysts

Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMTGet Free Report) have earned a consensus rating of “Moderate Buy” from the five brokerages that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $19.80.

A number of equities research analysts recently weighed in on the stock. HC Wainwright restated a “buy” rating and issued a $33.00 target price on shares of Calumet Specialty Products Partners in a report on Monday, March 3rd. UBS Group upgraded Calumet Specialty Products Partners from a “sell” rating to a “neutral” rating and decreased their price target for the stock from $15.00 to $12.00 in a report on Monday, March 17th. Wells Fargo & Company dropped their price objective on Calumet Specialty Products Partners from $28.00 to $23.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 9th. Finally, TD Cowen lowered shares of Calumet Specialty Products Partners from a “buy” rating to a “hold” rating and reduced their target price for the stock from $26.00 to $16.00 in a research note on Tuesday, March 4th.

View Our Latest Analysis on CLMT

Calumet Specialty Products Partners Price Performance

Shares of CLMT opened at $9.55 on Friday. The stock has a 50-day moving average of $12.27 and a 200-day moving average of $17.47. Calumet Specialty Products Partners has a one year low of $7.68 and a one year high of $25.29. The company has a market cap of $820.38 million, a PE ratio of -3.46 and a beta of 1.42.

Calumet Specialty Products Partners (NASDAQ:CLMTGet Free Report) last released its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) EPS for the quarter, beating the consensus estimate of ($1.06) by $0.59. The firm had revenue of $949.50 million for the quarter, compared to the consensus estimate of $921.76 million. During the same quarter in the prior year, the firm earned ($0.59) EPS. The company’s revenue was down 2.8% compared to the same quarter last year. Analysts expect that Calumet Specialty Products Partners will post -3.02 EPS for the current fiscal year.

Insider Transactions at Calumet Specialty Products Partners

In other news, CFO David Lunin purchased 2,500 shares of the company’s stock in a transaction dated Tuesday, March 4th. The shares were purchased at an average price of $13.05 per share, with a total value of $32,625.00. Following the transaction, the chief financial officer now directly owns 2,500 shares of the company’s stock, valued at approximately $32,625. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stephen P. Mawer sold 3,655 shares of the stock in a transaction on Monday, March 24th. The stock was sold at an average price of $12.88, for a total value of $47,076.40. Following the transaction, the director now owns 287,307 shares of the company’s stock, valued at $3,700,514.16. The trade was a 1.26 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.91% of the company’s stock.

Calumet Specialty Products Partners Company Profile

(Get Free Report

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Read More

Analyst Recommendations for Calumet Specialty Products Partners (NASDAQ:CLMT)

Receive News & Ratings for Calumet Specialty Products Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners and related companies with MarketBeat.com's FREE daily email newsletter.